skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Comprehensive Map of FDA-Approved Pharmaceutical Products
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Comprehensive Map of FDA-Approved Pharmaceutical Products

Zhong, Hao ; Chan, Ging ; Hu, Yuanjia ; Hu, Hao ; Ouyang, Defang

Pharmaceutics, 2018-12, Vol.10 (4), p.263 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
2
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
Material Type:
Artigo 		Adicionar ao Meu Espaço

2023 FDA TIDES (Peptides and Oligonucleotides) Harvest

Al Shaer, Danah ; Al Musaimi, Othman ; Albericio, Fernando ; de la Torre, Beatriz G

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.243 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
3
US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation
US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation
Material Type:
Artigo 		Adicionar ao Meu Espaço

US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation

Kim, Myung Sun ; Prasad, Vinay

Cancer, 2020-10, Vol.126 (19), p.4270-4272 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021

Martins, Alexander C. ; Oshiro, Mariana Y. ; Albericio, Fernando ; de la Torre, Beatriz G. ; Pereira, Gustavo José V. ; Gonzaga, Rodrigo V.

Biomedicines, 2022-09, Vol.10 (9), p.2325 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
5
Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story

Mor, Tsafrir S

Biotechnology Letters, 2015-11, Vol.37 (11), p.2147-2150 [Periódico revisado por pares]

Dordrecht: Springer Netherlands

Texto completo disponível

Citações Citado por
6
Zohydro approval by food and drug administration: controversial or frightening?
Zohydro approval by food and drug administration: controversial or frightening?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zohydro approval by food and drug administration: controversial or frightening?

Manchikanti, Laxmaiah ; Atluri, Sairam ; Candido, Kenneth D ; Boswell, Mark V ; Simopoulos, Thomas T ; Grider, Jay S ; Falco, Frank J E ; Hirsch, Joshua A

Pain physician, 2014-07, Vol.17 (4), p.E437-E450 [Periódico revisado por pares]

United States: American Society of Interventional Pain Physician

Texto completo disponível

Citações Citado por
7
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Safety Of Indacaterol/glycopyrrolate 27.5/15.6 µg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies

Ferguson, G T ; Donohue, J F ; Fucile, S ; Yadao, A ; Maitra, S ; Ayers, T ; Fogel, R ; Patalano, F ; Banerji, D

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Periódico revisado por pares]

New York: American Thoracic Society

Texto completo disponível

Citações Citado por
8
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Significant And Sustained Bronchodilation With Indacaterol/glycopyrrolate Versus Placebo: Pooled Analysis Of Flight1 And Flight2 Studies

Donohue, J F ; Kerwin, E M ; Fucile, S ; Yadao, A ; Maitra, S ; Ayers, T ; Fogel, R ; Patalano, F ; Banerji, D

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Periódico revisado por pares]

New York: American Thoracic Society

Texto completo disponível

Citações Citado por
9
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies
Material Type:
Artigo 		Adicionar ao Meu Espaço

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Significantly Reduces Nocturnal Rescue Medication Use And Awakenings In Patients With Moderate-To-Severe COPD: Results From a Pooled Analysis Of Flight1 And Flight2 Studies

Donohue, J F ; Kerwin, E M ; Fucile, S ; Yadao, A ; Thach, C ; Taylor, A Fowler ; Fogel, R ; Patalano, F ; Banerji, D

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Periódico revisado por pares]

New York: American Thoracic Society

Texto completo disponível

Citações Citado por
10
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis
C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Indacaterol/glycopyrrolate Is More Effective Than Placebo In Improving Fev1 By ≥200 Ml From Baseline In Patients With Moderate-To-Severe COPD: Flight1/flight2 Pooled Analysis

Kerwin, E M ; Mahler, D A ; Fucile, S ; Yadao, A ; Thach, C ; Taylor, A Fowler ; Fogel, R ; Patalano, F ; Banerji, D

American journal of respiratory and critical care medicine, 2017-01, Vol.195 [Periódico revisado por pares]

New York: American Thoracic Society

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (37.411)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (52.529)
  2. magazinearticle  (9.329)
  3. Newsletter Articles  (6.530)
  4. Artigos de Jornal  (6.100)
  5. Reports  (3.700)
  6. Resenhas  (152)
  7. Book Chapters  (49)
  8. Anais de Congresso  (13)
  9. Audio  (2)
  10. Livros  (1)
  11. Mais opções open sub menu

Assunto 

  1. Fda Approval  (77.337)
  2. Science & Technology  (32.199)
  3. Life Sciences & Biomedicine  (29.657)
  4. Humans  (15.270)
  5. Patients  (14.271)
  6. Clinical Trials  (13.621)
  7. Pharmaceutical Industry  (11.531)
  8. Drug Dosages  (9.192)
  9. Cancer Therapies  (8.359)
  10. Drugs  (7.975)
  11. Oncology  (6.669)
  12. Prescription Drugs  (6.132)
  13. Pharmacology & Pharmacy  (6.062)
  14. Tumors  (5.866)
  15. Proteins  (5.798)
  16. Cancer  (5.719)
  17. Drug Therapy  (5.260)
  18. Medical Research  (5.115)
  19. Chemotherapy  (5.103)
  20. Review  (4.888)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1986  (148)
  2. 1986Até1994  (1.209)
  3. 1995Até2003  (9.352)
  4. 2004Até2013  (16.348)
  5. Após 2013  (51.353)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (78.379)
  2. Japonês  (2.494)
  3. Português  (41)
  4. Chinês  (29)
  5. Turco  (22)
  6. Alemão  (21)
  7. Francês  (18)
  8. Norueguês  (17)
  9. Italiano  (9)
  10. Espanhol  (8)
  11. Holandês  (4)
  12. Coreano  (3)
  13. Polonês  (2)
  14. Russo  (1)
  15. Persa  (1)
  16. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.